TCL Archive Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item May 2, 1980
TCL Archive More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications February 24, 1984
TCL Archive John Durant Names ASCO Executive NP; A New Position, New Voice In Washington December 2, 1994
TCL Archive Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86 February 6, 1987
